To our knowledge, this is the first report to demonstrate that AOM and its active compound P-CA could promote adult hippocampal neurogenesis and improve cognitive impairment via inducing BDNF/TrkB/AKT signaling pathway in postischemic brains. The gene discussed is AKT1; the disease is Cognitive impairment.